The “monoclonal” antibody selectively targets both early-stage and advanced prostate cancer tumours. As well as attacking the disease directly, it aids the immune system to identify and destroy cancer cells.
A miracle molecule has been discovered that could save the lives of men with currently incurable prostate cancer.
The “monoclonal” antibody selectively targets both early-stage and advanced prostate cancer tumours. As well as attacking the disease directly, it aids the immune system to identify and destroy cancer cells.